Immunological investigations empower transplant drug trials

Affiliations

¹ Department of Surgery, Section of Experimental Surgery, University Hospital Regensburg, University of Regensburg, Regensburg 93053, Germany. Electronic address: edward.geissler@klinik.uni-regensburg.de.
² Department of Surgery, Section of Experimental Surgery, University Hospital Regensburg, University of Regensburg, Regensburg 93053, Germany.

Comment

Edward K Geissler et al. Lancet. 2018.

. 2018 Jun 30;391(10140):2578-2579.

doi: 10.1016/S0140-6736(18)31081-X. Epub 2018 Jun 14.

¹ Department of Surgery, Section of Experimental Surgery, University Hospital Regensburg, University of Regensburg, Regensburg 93053, Germany. Electronic address: edward.geissler@klinik.uni-regensburg.de.
² Department of Surgery, Section of Experimental Surgery, University Hospital Regensburg, University of Regensburg, Regensburg 93053, Germany.

No abstract available

Comment on

Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial.
Banham GD, Flint SM, Torpey N, Lyons PA, Shanahan DN, Gibson A, Watson CJE, O'Sullivan AM, Chadwick JA, Foster KE, Jones RB, Devey LR, Richards A, Erwig LP, Savage CO, Smith KGC, Henderson RB, Clatworthy MR. Banham GD, et al. Lancet. 2018 Jun 30;391(10140):2619-2630. doi: 10.1016/S0140-6736(18)30984-X. Epub 2018 Jun 14. Lancet. 2018. PMID: 29910042 Free PMC article. Clinical Trial.